|
|
Line 1: |
Line 1: |
− | <p align="center" style='text-align:center'><b><u><span style='font-size:16.0pt'>Sample
| + | #REDIRECT [[CDS]] |
− | Reminders from the Clinical Decision Support Expert Panel</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style='text-align:center'><i><span style='font-size:16.0pt'>Based on
| + | |
− | content from the Partners HealthCare</span></i></p>
| + | |
− | | + | |
− | <p><i> </i></p>
| + | |
− | | + | |
− | <p><b><span style='font-family:Arial;color:red'>It is important to note that, although
| + | |
− | we make this content available in good faith (and use much of it ourselves), neither
| + | |
− | the expert panel, the CERT-HIT, Brigham and Women's Hospital,
| + | |
− | Partners HealthCare or the Agency for Healthcare Research and Quality guarantee this
| + | |
− | content; it is provided as is and must be reviewed for correctness
| + | |
− | and completeness by any potential user.</span></b></p>
| + | |
− | | + | |
− | <p> </p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p class="Arial"><b><span style='font-family:Arial'>Needs Pneumovax (age > 65 and
| + | |
− | no Pneumovax ever)<br />
| + | |
− | <br /></span></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>142</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Vaccinations</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age >
| + | |
− | 65</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No Pneumovax on
| + | |
− | file</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order pneumovax</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Needs repeat
| + | |
− | pneumovax >65<br />
| + | |
− | <br /></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>143</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Vaccinations</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age >
| + | |
− | 65</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND one (and only one) pneumovax on
| + | |
− | file</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>latest pneumovax was
| + | |
− | performed 5 years ago and when patient was less</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>than 65 years of age</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span>Order pneumovax</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Needs
| + | |
− | Pneumovax (high risk medical condition)<br />
| + | |
− | <br /></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>144</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Vaccinations</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age
| + | |
− | 18-65</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient has a high risk medical
| + | |
− | condition</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No pneumovax on
| + | |
− | record</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order pneumovax</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p align="center" style='text-align:center;text-autospace:none'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial;color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Repeat
| + | |
− | Pneumovax (high risk medical condition)<br />
| + | |
− | <br /></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>145</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Vaccinations</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Patient
| + | |
− | has high risk medical condition</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>One and Only One
| + | |
− | pneumovax given >5 years ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Perform pneuomax</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; color:black;layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Influenza
| + | |
− | Vaccination Older Than 50<br />
| + | |
− | <br /></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>146</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Vaccinations</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age >
| + | |
− | 50</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Today is within flu
| + | |
− | season: Oct, Nov, Dec, Jan, Feb (Oct 1 to March</span> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>1), no previous vacc.</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Perform influenza vaccination.</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Needs
| + | |
− | Influenza Vaccination 18-50 (high risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>147</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Vaccinations</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age
| + | |
− | 18-50</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient has a high risk medical
| + | |
− | condition</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Today is within flu season: Oct,
| + | |
− | Nov, Dec, Jan, Feb</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>NO Flu shot during
| + | |
− | the current flu season</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Influenza Vaccine concept ID:
| + | |
− | 1516</span></p>
| + | |
− | </div><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:"Times New Roman";color:black; text-transform:uppercase;layout-grid-mode:line'><br clear="all"
| + | |
− | style='page-break-before: always' /></span></u></b>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Osteoporosis
| + | |
− | Management for At-Risk Populations<br />
| + | |
− | <br /></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>148</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Osteoporosis
| + | |
− | Prevention</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>((Female
| + | |
− | at least 65 years) OR</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>(Female 50-64 has risk factors for
| + | |
− | osteoporosis [smoking, past smoking, prior fracture since age 45, use of oral
| + | |
− | glucocorticoids for >=3 months or family history of osteoporosis))</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No osteoporosis meds
| + | |
− | on med list and no bone density scan on file</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span>Order bone densitometry</span></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p align="center" style='text-align:center;text-autospace:none'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial;color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Overdue for
| + | |
− | mammography (High FHx Risk)<br />
| + | |
− | <br /></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>149</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | A</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND High FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND age>40 yrs, <75
| + | |
− | yrs</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No mammogram in the
| + | |
− | past 12 months.</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Overdue for
| + | |
− | mammography (High FHx Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>150</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | B</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND High FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient is =< 40 years and >
| + | |
− | 25 years</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND (Age of youngest affected (with
| + | |
− | Breast cancer) relative - patient's age) < = 10 years
| + | |
− | )</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No mammogram in the
| + | |
− | past 12 months</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Overdue for
| + | |
− | mammography (Mod FHx Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><span style=
| + | |
− | 'font-size:10.0pt;color:black; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>151</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | A</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Mod FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient >40 years, <75
| + | |
− | yrs</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No mammogram in the
| + | |
− | past 12 months.</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span>Order m</span><span style='font-size:10.0pt;color:black'>ammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Overdue for
| + | |
− | mammography (Mod FHx Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>152</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | B</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Mod FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient is =< 40 and > 25
| + | |
− | years of age</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND(Age of youngest affected (with
| + | |
− | Breast cancer) relative - patient's age) <= 10
| + | |
− | years)</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No mammogram in the
| + | |
− | past 12 months.</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:"Times New Roman";color:black; text-transform:uppercase;layout-grid-mode:line'><br clear="all"
| + | |
− | style='page-break-before: always' /></span></u></b>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Overdue for
| + | |
− | mammography (Average Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>153</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | A</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Avg FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient is older than 40 years of
| + | |
− | age, <75 yrs</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>No mammogram in the
| + | |
− | past 12 months.</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span>Order m</span><span style='font-size:10.0pt;color:black'>ammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Almost due
| + | |
− | for mammography (High FHx Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>155</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | A</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND High FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient is older than 40 years of
| + | |
− | age, <75 yrs</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Last mammogram 10-12
| + | |
− | (inclusive) months ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Almost due
| + | |
− | for mammography (High FHx Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>156</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | B</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND High FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient is =< 40 and > 25
| + | |
− | years of age</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Age of youngest affected (with
| + | |
− | Breast cancer) relative - patient's age) <= 10
| + | |
− | years)</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Last mammogram 10-12
| + | |
− | (inclusive) months ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Almost due
| + | |
− | for mammography (Mod FHx Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>157</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | A</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Mod FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND older than 40 years of age, <75
| + | |
− | yrs</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Last mammogram 10-12
| + | |
− | (inclusive) months ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Almost due
| + | |
− | for mammography (Mod FHx Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>158</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | B</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Mod FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient is =< 40 and > 25
| + | |
− | years of age</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Age of youngest affected (with
| + | |
− | Breast cancer) relative - patient's age) <= 10 years</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Last mammogram 10-12
| + | |
− | (inclusive) months ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:"Times New Roman";color:black; text-transform:uppercase;layout-grid-mode:line'><br clear="all"
| + | |
− | style='page-break-before: always' /></span></u></b>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><u><span style=
| + | |
− | 'font-size: 10.0pt;color:black;text-transform:uppercase;layout-grid-mode:line'><span style='text-decoration:none'>
| + | |
− | </span></span></u></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Almost due
| + | |
− | for mammography (Average Risk)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>159</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Rule
| + | |
− | A</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Avg FHx Risk of Breast
| + | |
− | cancer</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Bilateral Mastectomy NOT on problem
| + | |
− | list</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND Patient is older than 40 years of
| + | |
− | age, <75 yrs</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Last mammogram 10-12
| + | |
− | (inclusive) months ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order mammogram</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Overdue for
| + | |
− | pap smear</span></u></b></p>
| + | |
− | | + | |
− | <p><b><span style=
| + | |
− | 'font-size:10.0pt;color:black;layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>161</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND age > 18 and < 65</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND hysterectomy and TAH-BSO not on
| + | |
− | problem list</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Last pap > 3
| + | |
− | years ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Perform pap</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; color:black;layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'>Almost due
| + | |
− | for pap smear</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black;layout-grid-mode:line'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>162</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span style='font-size:10.0pt;color:black'>Cancer
| + | |
− | Screening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>Female</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND age > 18 and < 65</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND hysterectomy and TAH-BSO not on
| + | |
− | problem list</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation
| + | |
− | Logic:</span></u></b> <span style='font-size:10.0pt;color:black'>Last pap 2.5 - 3
| + | |
− | years ago</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Recommendation</span></u></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Perform pap smear</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><span style=
| + | |
− | 'font-size:10.0pt; color:black'> </span></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'>NO risk factors, almost due for
| + | |
− | Lipids Assessment (male)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>192</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span>Lipid</span> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>creening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age
| + | |
− | <b>>35, <80</b></span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not diabetic</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND no CHD and its
| + | |
− | equivalents</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND FHx for CHD is AVERAGE</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND problem list does not contain
| + | |
− | smoking and hypertension</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND <b>male</b></span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>RISK GROUP
| + | |
− | DEFINITION</span></u></span></b> <span style='font-size:10.0pt;color:black'>No total
| + | |
− | cholesterol in >54 months or no previous data</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND No LDL in >54 months or no
| + | |
− | previous data</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style=
| + | |
− | 'color:black; text-transform:uppercase'>Recommendation</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order lipid panel</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'></p>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'>NO risk factors, almost due for
| + | |
− | Lipids Assessment (female)</span></u></b></p>
| + | |
− | | + | |
− | <p><b><span style='font-size:10.0pt;color:black'> </span></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>193</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span>Lipid</span> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>creening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age
| + | |
− | <b>>45, <80</b></span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not diabetic</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND no CHD and its
| + | |
− | equivalents</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND FHx for CHD is AVERAGE</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND problem list does not contain
| + | |
− | smoking and hypertension</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND <b>female</b></span></p>
| + | |
− | | + | |
− | <p><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>AND</span>
| + | |
− | <span style='font-size:10.0pt; color:black'>No total cholesterol in >54 months or
| + | |
− | no previous data</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND No LDL in >54 months or no
| + | |
− | previous data</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style=
| + | |
− | 'color:black; text-transform:uppercase'>Recommendation</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order lipid panel</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Literature/ref.</span></u></b></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>1. NCEP/ATP III. Executive Summary of
| + | |
− | the Third Report of the NCEP Expert Panel on Detection, Evaluation, and</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Treatment of High Blood Cholesterol in
| + | |
− | Adults (ATP III). JAMA, Vol 285 (19): 2486-2497.</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>2. USPSTF. Screening Adults for Lipid
| + | |
− | Disorders. Am J Prev Med. 2001; 20 (3S): 73-76.</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><span style=
| + | |
− | 'font-size:10.0pt; color:black'> </span></p><span style=
| + | |
− | 'font-size:10.0pt;font-family:"Times New Roman";color:black'><br clear="all" style=
| + | |
− | 'page-break-before:always' /></span>
| + | |
− | | + | |
− | <p style='text-autospace:none'><span style=
| + | |
− | 'font-size:10.0pt; color:black'> </span></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'>LMR Reminder: NO risk factors,
| + | |
− | Overdue for Lipids Assessment (Male)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>190</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span>Lipid</span> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>creening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age
| + | |
− | <b>>35, <80</b></span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not diabetic</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND no CHD and its
| + | |
− | equivalents</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND FHx for CHD is AVERAGE (change it
| + | |
− | to NOT(moderate or high)</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND problem list does not contain
| + | |
− | smoking and hypertension</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND <b>male</b></span></p>
| + | |
− | | + | |
− | <p><span>AND </span><span style='font-size:10.0pt;color:black'>no total cholesterol
| + | |
− | in >5 years or no previous data</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND No LDL in >5 years or no
| + | |
− | previous data</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style=
| + | |
− | 'color:black; text-transform:uppercase'>Recommendation</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order lipid panel</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><b><span style=
| + | |
− | 'font-size:10.0pt; layout-grid-mode:line'> </span></b></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'>LMR Reminder: NO risk factors,
| + | |
− | Overdue for Lipids Assessment (female)</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>191</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span>Lipid</span> <span style=
| + | |
− | 'font-size:10.0pt;color:black'>creening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age
| + | |
− | <b>>45, <80</b></span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not diabetic</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND no CHD and its
| + | |
− | equivalents</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND FHx for CHD is AVERAGE (change it
| + | |
− | to NOT(moderate or high)</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND problem list does not contain
| + | |
− | smoking and hypertension</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND <b>female</b></span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND </span><span style=
| + | |
− | 'font-size: 10.0pt;color:black'>No total cholesterol in >5 years or no previous
| + | |
− | data</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND No LDL in >5 years or no
| + | |
− | previous data</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style=
| + | |
− | 'color:black; text-transform:uppercase'>Recommendation</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order lipid panel</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Literature/ref.</span></u></b></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>1. NCEP/ATP III. Executive Summary of
| + | |
− | the Third Report of the NCEP Expert Panel on Detection, Evaluation, and</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Treatment of High Blood Cholesterol in
| + | |
− | Adults (ATP III). JAMA, Vol 285 (19): 2486-2497.</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>2. USPSTF. Screening Adults for Lipid
| + | |
− | Disorders. Am J Prev Med. 2001; 20 (3S): 73-76.</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'><span style=
| + | |
− | 'font-size:10.0pt; color:black'> </span></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'>LMR Reminder: Risk Factor: Family
| + | |
− | History, Almost due for Lipids Assessment</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>188</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span>Lipid s</span><span style=
| + | |
− | 'font-size:10.0pt;color:black'>creening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age>20
| + | |
− | and <80</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not diabetic</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not CHD equivalent</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND FHx risk for CHD is
| + | |
− | MODERATE</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND no total cholesterol or no previous
| + | |
− | data</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND No LDL or no previous data > 54
| + | |
− | months</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style=
| + | |
− | 'color:black; text-transform:uppercase'>Recommendation</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order lipid panel</span></p>
| + | |
− | </div>
| + | |
− | | + | |
− | <p style='text-autospace:none'></p>
| + | |
− | | + | |
− | <div style='border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt'>
| + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'>LMR Reminder: Risk Factor: Family
| + | |
− | History, Almost due for Lipid Assessment</span></u></b></p>
| + | |
− | | + | |
− | <p align="center" style=
| + | |
− | 'text-align:center;text-autospace:none; border:none;padding:0in'><b><u><span style=
| + | |
− | 'font-size:10.0pt;font-family:Arial; color:black'><span style=
| + | |
− | 'text-decoration:none'> </span></span></u></b></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Rule#:</span></u>
| + | |
− | <span style='color:black'>189</span> <u><span style=
| + | |
− | 'color:black;text-transform:uppercase'>Rule category</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Health Maintenance</span>
| + | |
− | <b><span><u><span style='color:black;text-transform:uppercase'>Primary Clinical
| + | |
− | Area</span></u></span></b> <span>Lipid s</span><span style=
| + | |
− | 'font-size:10.0pt;color:black'>creening</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style='color:black; text-transform:uppercase'>Risk Group
| + | |
− | Definition</span></u></span></b> <span style='font-size:10.0pt;color:black'>Age>20
| + | |
− | and <80</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not diabetic</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND not CHD equivalent</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND problem list contains HTN OR
| + | |
− | smoking</span></p>
| + | |
− | | + | |
− | <p><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>AND</span>
| + | |
− | <span style='font-size:10.0pt; color:black'>No total cholesterol in >54 months or
| + | |
− | no previous data</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>AND No LDL in >54 months or no
| + | |
− | previous data</span></p>
| + | |
− | | + | |
− | <p><b><span><u><span style=
| + | |
− | 'color:black; text-transform:uppercase'>Recommendation</span></u></span></b>
| + | |
− | <span style='font-size:10.0pt;color:black'>Order lipid panel</span></p>
| + | |
− | | + | |
− | <p><b><u><span style=
| + | |
− | 'font-size:10.0pt;color:black;text-transform:uppercase;layout-grid-mode: line'>Literature/ref.</span></u></b></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>1. NCEP/ATP III. Executive Summary of
| + | |
− | the Third Report of the NCEP Expert Panel on Detection, Evaluation, and</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>Treatment of High Blood Cholesterol in
| + | |
− | Adults (ATP III). JAMA, Vol 285 (19): 2486-2497.</span></p>
| + | |
− | | + | |
− | <p><span style='font-size:10.0pt;color:black'>2. USPSTF. Screening Adults for Lipid
| + | |
− | Disorders. Am J Prev Med. 2001; 20 (3S): 73-76.</span></p>
| + | |
− | </div>
| + | |